Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ion Pacific is a financial organization founded in 2015 by Itamar Har-Even and Michael Joseph. The firm operates in multiple locations across the US, Europe, and Asia, focusing on structured investments in secondary opportunities within the venture-stage technology sector. Ion Pacific aims to provide better return-risk potential than traditional venture capital by offering sophisticated financing structures.
The organization specializes in helping general partners (GPs), limited partners (LPs), and founders meet liquidity needs while allowing investors to benefit from future asset upside. Ion Pacific has established itself as a key player in the venture capital space, managing several funds that reflect its commitment to structured secondaries.
As of now, Ion Pacific manages multiple funds, including Stonecutter, Pathway, and Southeast Asia Opportunities, which target various sectors and regions. The firm continues to evolve its investment strategy to adapt to the changing landscape of venture capital.
Ion Pacific invests in venture-stage companies through a structured secondaries approach, which combines downside protection with uncapped upside return potential. This unique strategy allows the firm to target general partners (GPs), limited partners (LPs), and founders, helping them meet liquidity needs while providing investors with opportunities for future asset appreciation.
The organization focuses on several key sectors, including healthcare, biotech, and fintech, with a global investment strategy that spans North America, Europe, and Asia. Ion Pacific manages several funds, including:
Ion Pacific's investment strategy emphasizes structured secondaries, allowing for a balance of risk and reward that is appealing to both founders and investors.
Ion Pacific's portfolio includes a variety of venture-stage companies across its focus sectors, although specific names and descriptions of notable portfolio companies were not provided. The firm’s structured secondaries approach allows it to invest in companies that are positioned for growth while providing liquidity solutions.
While the exact details of the portfolio remain undisclosed, the firm’s emphasis on healthcare, biotech, and fintech suggests a diverse range of innovative companies within these sectors. The structured secondaries model enables Ion Pacific to engage with companies at various stages of their development, enhancing their potential for success.
Itamar Har-Even: Co-CEO, Managing Partner, and Investment Committee Member. He has extensive experience in venture capital and structured investments.
Michael Joseph: Co-CEO, Managing Partner, and Investment Committee Member. He co-founded Ion Pacific and has a strong background in finance and investment strategies.
Ady Adefris: Managing Director and Chief Operating Officer, responsible for overseeing operations and strategic initiatives.
Kristaps Ronis: Partner with expertise in venture capital and investment management.
Kevin Henderson: Partner, focusing on investment strategies and portfolio management.
Jonathan Chia: Associate, involved in deal sourcing and analysis.
Katie Young: Analyst, supporting investment research and portfolio management.
Fabio Furlani: Analyst, contributing to financial analysis and market research.
Henry Fung: Analyst, assisting in investment evaluations and due diligence.
Daniele Brocca: Analyst, focused on data analysis and investment insights.
Najeh Albustami: Partner, bringing experience in venture capital and strategic investments.
To pitch Ion Pacific, founders should send their pitch deck via email to info@ionpacific.com. The deck should include a clear overview of the business, market opportunity, and financial projections.
Founders are encouraged to provide detailed information about their team and any traction they have achieved. A warm introduction can be beneficial but is not strictly necessary. Response times may vary, so founders should be prepared for potential follow-up discussions.
In 2021, Ion Pacific launched the Pathway fund, focusing on life sciences and applying their structured secondaries approach to healthcare and med-tech investments.
In 2022, the firm introduced the Southeast Asia Opportunities fund, targeting VC investments specifically in Southeast Asia.
Ion Pacific continues to manage its Stonecutter fund, which is currently on its third vintage since its inception in 2018, reflecting the firm's ongoing commitment to structured secondaries in diverse sectors.
What are Ion Pacific's investment criteria?
Ion Pacific focuses on venture-stage companies in healthcare, biotech, and fintech sectors. They employ a structured secondaries approach that combines downside protection with uncapped upside potential.
How can I pitch to Ion Pacific?
Founders can reach out via email at info@ionpacific.com. A well-prepared pitch deck should include details about the business model, market opportunity, and financial projections.
What makes Ion Pacific different from other VCs?
Ion Pacific specializes in structured secondaries investments, which provide liquidity solutions while maintaining growth potential. This approach is designed to benefit both founders and investors.
What is the geographic scope of Ion Pacific's investments?
Ion Pacific invests globally, with a focus on North America, Europe, and Asia. Their funds target opportunities in these regions, particularly in the healthcare, biotech, and fintech sectors.
What is the typical check size for investments?
While specific check sizes are not disclosed, Ion Pacific's structured secondaries approach typically allows for flexible investment amounts tailored to the needs of the companies they support.
What kind of post-investment involvement does Ion Pacific have?
Ion Pacific aims to provide ongoing support to portfolio companies through strategic guidance and access to their network of investors, enhancing the potential for growth and success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.